These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 30021582)
1. Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology. Rout-Pitt N; Farrow N; Parsons D; Donnelley M Respir Res; 2018 Jul; 19(1):136. PubMed ID: 30021582 [TBL] [Abstract][Full Text] [Related]
2. Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target? Mottais A; Riberi L; Falco A; Soccal S; Gohy S; De Rose V Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569787 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition. Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG; Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020 [TBL] [Abstract][Full Text] [Related]
6. A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis. Nyabam S; Wang Z; Thibault T; Oluseyi A; Basar R; Marshall L; Griffin M Biochim Biophys Acta; 2016 Sep; 1863(9):2234-44. PubMed ID: 27234323 [TBL] [Abstract][Full Text] [Related]
7. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Guarino M; Tosoni A; Nebuloni M Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients. Nishioka M; Venkatesan N; Dessalle K; Mogas A; Kyoh S; Lin TY; Nair P; Baglole CJ; Eidelman DH; Ludwig MS; Hamid Q Respir Res; 2015 Jun; 16(1):72. PubMed ID: 26081431 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease. Jolly MK; Ward C; Eapen MS; Myers S; Hallgren O; Levine H; Sohal SS Dev Dyn; 2018 Mar; 247(3):346-358. PubMed ID: 28646553 [TBL] [Abstract][Full Text] [Related]
10. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process. Lee HM; Hwang KA; Choi KC Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023 [TBL] [Abstract][Full Text] [Related]
11. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Mall MA Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954 [TBL] [Abstract][Full Text] [Related]
12. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation. Tomei P; Masola V; Granata S; Bellin G; Carratù P; Ficial M; Ventura VA; Onisto M; Resta O; Gambaro G; Chilosi M; Lupo A; Zaza G J Nephrol; 2016 Dec; 29(6):881-891. PubMed ID: 27026415 [TBL] [Abstract][Full Text] [Related]
13. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis. Sun H; Chen J; Qian W; Kang J; Wang J; Jiang L; Qiao L; Chen W; Zhang J J Cell Mol Med; 2016 Jul; 20(7):1234-46. PubMed ID: 26824344 [TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Bartis D; Mise N; Mahida RY; Eickelberg O; Thickett DR Thorax; 2014 Aug; 69(8):760-5. PubMed ID: 24334519 [TBL] [Abstract][Full Text] [Related]
16. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition. Gohy ST; Hupin C; Fregimilicka C; Detry BR; Bouzin C; Gaide Chevronay H; Lecocq M; Weynand B; Ladjemi MZ; Pierreux CE; Birembaut P; Polette M; Pilette C Eur Respir J; 2015 May; 45(5):1258-72. PubMed ID: 25745049 [TBL] [Abstract][Full Text] [Related]
17. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis. Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196 [TBL] [Abstract][Full Text] [Related]
18. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects. Kuk K; Taylor-Cousar JL Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827 [TBL] [Abstract][Full Text] [Related]
19. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Serrano-Gomez SJ; Maziveyi M; Alahari SK Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733 [TBL] [Abstract][Full Text] [Related]
20. The effect of sesamin on airway fibrosis in vitro and in vivo. Lin CH; Shen ML; Kao ST; Wu DC Int Immunopharmacol; 2014 Sep; 22(1):141-50. PubMed ID: 24978608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]